Berry Street Merges With Healthify to Power Global Nutrition Care in GLP-1 Era

US based nutrition startup Berry Street has merged with Indian counterpart Healthify to strengthen services around popular weight loss medications.

The deal combines clinical expertise with advanced digital tools at a time when demand for such support is growing fast.

The Rise of GLP-1 Medications

GLP-1 drugs help many people manage weight effectively and are expected to reach over 30 million users in the United States alone by 2030.

These medications work best when paired with proper nutrition guidance to maintain results and avoid side effects.

Both companies already offer programs that integrate these drugs with coaching which positions the new entity well for expansion.

The merger creates a larger platform with operations under the Berry Street name in America and Healthify elsewhere.

What This Means for Consumers Worldwide

Everyday people will gain easier access to personalized diet plans and expert advice alongside medical treatments.

The combined company brings together thousands of clinics and millions of app users creating scale that could lower costs over time.

Future growth may include more insurance partnerships and AI features that track progress in real time.

This trend highlights how technology and traditional care are coming together to tackle rising health issues like obesity.

Long term the partnership could influence global standards for metabolic support and improve outcomes for many families.